Characterization of a novel family of human transcription factors that bind at +240 downstream of the transcription start site.
Characterization of a novel family of human transcription factors that bind at +240 downstream of the transcription start site.
批准号:
10589127
负责人:
PEGGY J Farnham
金额:
$33.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-01 至 2024-03-31
关键词:
AffectBindingBinding SitesBiological AssayC2H2 Zinc FingerCRISPR/Cas technologyCell LineCell ProliferationCellsChIP-seqChromatinChromatin StructureCpG IslandsDNA BindingDNA Binding DomainDNA MethylationDiseaseElementsFailureFamilyFamily memberFemaleGenesGenetic TranscriptionHumanHuman Cell LineInvestigationLocationMapsMediatingNuclear ExtractNucleosomesPatternPositioning AttributePromoter RegionsProteinsProteomicsQualifyingRNAReporterRoleSeriesTechniquesTestingTranscription ElongationTranscription InitiationTranscription Initiation SiteTranscriptional RegulationY ChromosomeZFY proteinZinc Fingerscell typeepigenomicsgenome-wide analysishistone modificationhuman diseaseinsightnovelnovel therapeuticspromoterprotein protein interactionprotein structurerecruittranscription factortranscriptometranscriptomics
中文摘要
我们的研究集中在一个由ZFX、ZFY和ZNF 711组成的人类C2 H2锌指蛋白家族
在所有人类细胞类型中都有表达。在我们的初步研究中,我们发现ZFX的缺失
家族成员对细胞增殖具有严重的有害后果。我们进行了ChIP-
在几种不同的人细胞系中进行ZFX、ZFY和ZNF 711的seq测定。有趣的是,我们发现,
这些TF在相同的CpG岛启动子区域具有相同的结合模式,
在转录起始位点下游+240bp处结合。尽管它们的蛋白质结构表明
ZFX、ZFY和ZNF 711是转录调节因子,它们影响转录的机制
转录尚未阐明。我们的初步结果表明,ZXF家族成员
是人类转录组的重要调节因子。未能适当监管
转录组可导致多种人类疾病。因此,彻底描述这一点
TF家族至关重要。两个家族成员(ZFX和ZFY)基本相同
在X或Y染色体上编码的蛋白质,而ZNF 711与ZFX具有67%的总体相似性
锌指结构域的相似性为87%。因为ZFX和ZFY基本上是相同的蛋白质,我们将
集中于使用雌性细胞系(其缺乏ZFY)比较ZFX和ZNF 711。我们建议
描述这些因子通过三管齐下的方法调节转录的机制。在
目的1,我们将进行ZFX和ZNF 711结合的详细研究,以确定这些结合是如何发生的。
转录因子被募集到CpG岛启动子。在目标2中,我们将确定关键的监管
ZFX和ZNF 711的结构域和相互作用蛋白。在目标3中,我们将通过以下方式描述该机制:
ZFX和ZNF 711介导转录调控。重要的是,每个目标都可以实现
独立于其他人,并可以立即开始开始。通过目标1-3的结合,我们将
使用表观基因组学、蛋白质组学和转录组学方法彻底表征ZFX家族的功能。
方法。完成我们提出的研究将提供新的见解转录
调控和染色质结构在人类CpG岛启动子。
英文摘要
Our study focuses on a family of human C2H2 zinc finger proteins composed of ZFX, ZFY, and ZNF711
which are expressed in all human cell types. In our preliminary studies, we show that deletion of ZFX
family members has severe detrimental consequences on cell proliferation. We have performed ChIP-
seq assays for ZFX, ZFY, and ZNF711 in several different human cell lines. Interestingly, we found that
these TFs have identical binding patterns at the same CpG island promoter regions, with an average peak
of binding at +240bp downstream of the transcription start site. Although their protein structure suggests
that ZFX, ZFY, and ZNF711 are transcriptional regulators, the mechanisms by which they influence
transcription have not yet been elucidated. Our preliminary results suggest that the ZXF family members
are important regulators of the human transcriptome. A failure to properly regulate the
transcriptome can lead to many types of human disease. Therefore, a thorough characterization of this
family of TFs is of critical importance. Two of the family members (ZFX and ZFY) are essentially identical
proteins encoded on either the X or Y chromosome, whereas ZNF711 has 67% overall similarity with ZFX
and 87% similarity in the zinc finger domain. Because ZFX and ZFY are basically identical proteins, we will
focus on a comparison of ZFX and ZNF711 using a female cell line (which lacks ZFY). We propose to
characterize the mechanisms by which these factors regulate transcription using a 3-pronged approach. In
Aim 1, we will perform detailed investigations of ZFX and ZNF711 binding to determine how these
transcription factors are recruited to CpG island promoters. In Aim 2, we will identify critical regulatory
domains and interacting proteins of ZFX and ZNF711. In Aim 3, we will characterize the mechanism by
which ZFX and ZNF711 mediate transcriptional regulation. Importantly, each of the Aims can be performed
independently of the others and can begin immediately. Through the combination of Aims 1-3, we will
thoroughly characterize the function of the ZFX family using epigenomic, proteomic, and transcriptomic
approaches. Completion of our proposed studies will provide new insights into transcriptional
regulation and chromatin structure at human CpG island promoters.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Characterization of a novel family of human transcription factors that bind at +240 downstream of the transcription start site.
-
批准号:10361502
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2020
-
负责人:PEGGY J Farnham
-
依托单位:
Core-009
-
批准号:9387393
-
项目类别:
-
资助金额:$64.91万
-
财政年份:2017
-
负责人:PEGGY J Farnham
-
依托单位:
Core-009
-
批准号:9784284
-
项目类别:
-
资助金额:$0.2万
-
财政年份:2017
-
负责人:PEGGY J Farnham
-
依托单位:
ADMINISTRATION (Admin Core)
-
批准号:9387384
-
项目类别:
-
资助金额:$136.93万
-
财政年份:2017
-
负责人:PEGGY J Farnham
-
依托单位:
The USC PsychENCODE Project
-
批准号:8677649
-
项目类别:
-
资助金额:$65.0万
-
财政年份:2014
-
负责人:PEGGY J Farnham
-
依托单位:
The USC PsychENCODE Project
-
批准号:9254195
-
项目类别:
-
资助金额:$16.01万
-
财政年份:2014
-
负责人:PEGGY J Farnham
-
依托单位:
The USC PsychENCODE Project
-
批准号:9052536
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2014
-
负责人:PEGGY J Farnham
-
依托单位:
The USC PsychENCODE Project
-
批准号:9505455
-
项目类别:
-
资助金额:$12.89万
-
财政年份:2014
-
负责人:PEGGY J Farnham
-
依托单位:
The USC PsychENCODE Project
-
批准号:8869039
-
项目类别:
-
资助金额:$65.0万
-
财政年份:2014
-
负责人:PEGGY J Farnham
-
依托单位:
Development of a nuclease-mediated technology to validate chromatin hubs
-
批准号:8308770
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2012
-
负责人:PEGGY J Farnham
-
依托单位:
Development of a nuclease-mediated technology to validate chromatin hubs
-
批准号:8463009
-
项目类别:
-
资助金额:$20.64万
-
财政年份:2012
-
负责人:PEGGY J Farnham
-
依托单位:
Scaling the ChIP-chip assay to improve analysis of clinical biospecimens
-
批准号:7279478
-
项目类别:
-
资助金额:$22.79万
-
财政年份:2007
-
负责人:PEGGY J Farnham
-
依托单位:
Scaling the ChIP-chip assay to improve analysis of clinical biospecimens
-
批准号:7442311
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2007
-
负责人:PEGGY J Farnham
-
依托单位:
Mechanisms of Transcriptional Regulation in Stem Cells
-
批准号:7242623
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2005
-
负责人:PEGGY J Farnham
-
依托单位:
Mechanisms of Transcriptional Regulation in Stem Cells
-
批准号:6915856
-
项目类别:
-
资助金额:$22.17万
-
财政年份:2005
-
负责人:PEGGY J Farnham
-
依托单位:
Mechanisms of Transcriptional Regulation in Stem Cells
-
批准号:7082005
-
项目类别:
-
资助金额:$21.66万
-
财政年份:2005
-
负责人:PEGGY J Farnham
-
依托单位:
CELLULAR GROWTH CONTROL IN HEPATOCARCINOGENESIS
-
批准号:6300176
-
项目类别:
-
资助金额:$23.98万
-
财政年份:2000
-
负责人:PEGGY J Farnham
-
依托单位:
CELLULAR GROWTH CONTROL IN HEPATOCARCINOGENESIS
-
批准号:6101947
-
项目类别:
-
资助金额:$23.98万
-
财政年份:1999
-
负责人:PEGGY J Farnham
-
依托单位:
CELLULAR GROWTH CONTROL IN HEPATOCARCINOGENESIS
-
批准号:6269041
-
项目类别:
-
资助金额:$22.1万
-
财政年份:1998
-
负责人:PEGGY J Farnham
-
依托单位:
CORE--FLOW CYTOMETRY FACILITY
-
批准号:6235971
-
项目类别:
-
资助金额:$25.57万
-
财政年份:1996
-
负责人:PEGGY J Farnham
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: